{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:37:03Z","timestamp":1792143423862,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13550-018-0408-2","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T06:52:47Z","timestamp":1530600767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Impact of external cooling with icepacks on 68Ga-PSMA uptake in salivary glands"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6243-5187","authenticated-orcid":false,"given":"Ludwike W. M.","family":"van Kalmthout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marnix G. E. H.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"de Keizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard C.","family":"Krijger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa F. T.","family":"Ververs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rememrt","family":"de Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur J. A. T.","family":"Braat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"issue":"1","key":"408_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/1078-1439(95)00002-Y","volume":"1","author":"GL Wright Jr","year":"1995","unstructured":"Wright GL Jr, Haley C, Beckett ML, Schellhammer PF. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. Urol Oncol. 1995;1(1):18\u201328.","journal-title":"Urol Oncol"},{"issue":"3","key":"408_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.urolonc.2013.09.003","volume":"32","author":"BT Ristau","year":"2014","unstructured":"Ristau BT, O'Keefe DS, Bacich DJ. The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research. Urol Oncol. 2014;32(3):272\u20139.","journal-title":"Urol Oncol"},{"issue":"11","key":"408_CR3","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.2967\/jnumed.115.161299","volume":"56","author":"A Afshar-Oromieh","year":"2015","unstructured":"Afshar-Oromieh A, Hetzheim H, Kratochwil C, Benesova M, Eder M, Neels OC, Eisenhut M, K\u00fcbler W, Holland-Letz T, Giesel FL, Mier W, Kopka K, Haberkorn U. The theranostic PSMA ligand PSMA-617 in the diagnosis of prostate cancer by PET\/CT: biodistribution in humans, radiation dosimetry, and first evaluation of tumor lesions. J Nucl Med. 2015;56(11):1697\u2013705.","journal-title":"J Nucl Med"},{"key":"408_CR4","doi-asserted-by":"crossref","unstructured":"Klein Nulent TJW, Valstar MH, de Keizer B, Willems SM, Smit LA, Al-Mamgani A, Smeele LE, van Es RJJ, de Bree R, Vogel WV. Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET\/CT. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(5):478\u201386.","DOI":"10.1016\/j.oooo.2018.01.011"},{"key":"408_CR5","first-page":"1627","volume":"38","author":"A Braat","year":"2017","unstructured":"Braat A, Ahmadzadehfar H. Lutetium-177 labelled PSMA ligands for the treatment of metastatic castrate-resistant prostate cancer. Tijdschr Nucl Geneesk. 2017;38:1627\u201334.","journal-title":"Tijdschr Nucl Geneesk"},{"issue":"8","key":"408_CR6","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.2967\/jnumed.117.191023","volume":"58","author":"WP Fendler","year":"2017","unstructured":"Fendler WP, Rahbar K, Herrmann K, Kratochwil C, Eiber M. 177Lu-PSMA radioligand therapy for prostate cancer. J Nucl Med. 2017;58(8):1196\u2013200.","journal-title":"J Nucl Med"},{"key":"408_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJG, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"408_CR8","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","volume":"44","author":"WP Fendler","year":"2017","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, Giesel F, Haberkorn U, Hope TA, Kopka K, Krause BJ, Mottaghy FM, Sch\u00f6der H, Sunderland J, Wan S, Wester HJ, Fanti S, Herrmann K. Ga-PSMA PET\/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1. 0 Eur J Nucl Med Mol Imaging. 2017;44(6):1014\u201324.","journal-title":"0 Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"408_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1088\/0967-3334\/28\/8\/006","volume":"28","author":"FP Janssen","year":"2007","unstructured":"Janssen FP, Rajan V, Steenbergen W, van Leeuwen GM, van Steenhoven AA. The relationship between local scalp skin temperature and cutaneous perfusion during scalp cooling. Physiol Meas. 2007;28(8):829\u201339.","journal-title":"Physiol Meas"},{"key":"408_CR10","doi-asserted-by":"crossref","unstructured":"Rugo HS, Voigt J. Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clin Breast Cancer. 2018;18(1):19\u201328.","DOI":"10.1016\/j.clbc.2017.07.012"},{"key":"408_CR11","doi-asserted-by":"crossref","unstructured":"Ta\u00efeb D, Foletti JM, Bardi\u00e8s M, Rocchi P, Hicks RJ, Haberkorn U. PSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter? J Nucl Med. 2018;59(5):747\u201348.","DOI":"10.2967\/jnumed.118.207993"},{"key":"408_CR12","volume-title":"EAMN 2015","author":"FC Gaertner","year":"2015","unstructured":"Gaertner FC, Ahmadzadehfar H, Bundschuh RA, K\u00fcrpig S, Eppard E, Essler M. Does cooling of the salivary glands reduce uptake of radiolabeled PSMA-ligands? In: EAMN 2015; 2015."},{"key":"408_CR13","doi-asserted-by":"publisher","first-page":"A2","DOI":"10.1055\/s-0038-1622575","volume":"56","author":"KP Bohn","year":"2017","unstructured":"Bohn KP, Kletting P, Solbach C, Beer AJ, Krohn T. Effekt der K\u00fchlung von Speicheldr\u00fcsen bei der Therapie mit PSMA-Radioliganden. Nuklearmedizin. 2017;56:A2\u2013A91.","journal-title":"Nuklearmedizin"},{"key":"408_CR14","first-page":"114","volume":"5","author":"H Ahmadzadehfar","year":"2015","unstructured":"Ahmadzadehfar H, Rahbar K, Kurpig S, et al. Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study. EJNMMI Res. 2015;5:114.","journal-title":"EJNMMI Res"},{"key":"408_CR15","doi-asserted-by":"publisher","first-page":"12477","DOI":"10.18632\/oncotarget.7245","volume":"7","author":"H Ahmadzadehfar","year":"2016","unstructured":"Ahmadzadehfar H, Eppard E, Kurpig S, et al. Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate resistant metastatic prostate cancer. Oncotarget. 2016;7:12477\u201388.","journal-title":"Oncotarget"},{"issue":"7","key":"408_CR16","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2967\/jnumed.115.168443","volume":"57","author":"RP Baum","year":"2016","unstructured":"Baum RP, Kulkarni HR, Schuchardt C, Singh A, Wirtz M, Wiessalla S, Schottelius M, Mueller D, Klette I, Wester HJ. 177Lu-labeled prostate-specific membrane antigen radioligand therapy of metastatic castration-resistant prostate cancer: safety and efficacy. J Nucl Med. 2016;57(7):1006\u201313.","journal-title":"J Nucl Med"},{"issue":"2","key":"408_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.juro.2016.02.2969","volume":"196","author":"MM Heck","year":"2016","unstructured":"Heck MM, Retz M, D'Alessandria C, Rauscher I, Scheidhauer K, Maurer T, Storz E, Janssen F, Schottelius M, Wester HJ, Gschwend JE, Schwaiger M, Tauber R, Eiber M. Systemic radioligand therapy with (177)Lu labeled prostate specific membrane antigen ligand for imaging and therapy in patients with metastatic castration resistant prostate cancer. J Urol. 2016;196(2):382\u201391. \n                    https:\/\/doi.org\/10.1016\/j.juro.2016.02.2969\n                    \n                  . Epub 2016 Mar 8","journal-title":"J Urol"},{"key":"408_CR18","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.2967\/jnumed.115.171397","volume":"57","author":"C Kratochwil","year":"2016","unstructured":"Kratochwil C, Giesel FL, Stefanova M, et al. PSMA-targeted radionuclide therapy of metastatic castration-resistant prostate cancer with Lu-177 labeled PSMA-617. J Nucl Med. 2016;57:1170\u20136.","journal-title":"J Nucl Med"},{"issue":"7","key":"408_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/RLU.0000000000001240","volume":"41","author":"K Rahbar","year":"2016","unstructured":"Rahbar K, Bode A, Weckesser M, Avramovic N, Claesener M, Stegger L, B\u00f6gemann M. Radioligand therapy with 177Lu-PSMA-617 as a novel therapeutic option in patients with metastatic castration resistant prostate Cancer. Clin Nucl Med. 2016;41(7):522\u20138.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"408_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2967\/jnumed.116.183194","volume":"58","author":"K Rahbar","year":"2017","unstructured":"Rahbar K, Ahmadzadehfar H, Kratochwil C, Haberkorn U, Sch\u00e4fers M, Essler M, Baum RP, Kulkarni HR, Schmidt M, Drzezga A, Bartenstein P, Pfestroff A, Luster M, L\u00fctzen U, Marx M, Prasad V, Brenner W, Heinzel A, Mottaghy FM, Ruf J, Meyer PT, Heuschkel M, Eveslage M, B\u00f6gemann M, Fendler WP, Krause BJ. German multicenter study investigating 177Lu-PSMA-617 radioligand therapy in advanced prostate cancer patients. J Nucl Med. 2017;58(1):85\u201390.","journal-title":"J Nucl Med"},{"key":"408_CR21","doi-asserted-by":"publisher","first-page":"H208","DOI":"10.1152\/ajpheart.1996.270.1.H208","volume":"270","author":"PE P\u00e9rgola","year":"1996","unstructured":"P\u00e9rgola PE, Johnson JM, Kellogg DL Jr, Kosiba WA. Control of skin blood flow by whole body and local skin cooling in exercising humans. Am J Physiol Heart Circ Physiol. 1996;270:H208\u201315.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"408_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00411-017-0721-6","volume":"57","author":"M Abuqbeitah","year":"2018","unstructured":"Abuqbeitah M, Demir M, Uslu-Be\u015fli L, Yeyin N, S\u00f6nmezo\u011flu K. Blood clearance and occupational exposure for 177Lu-DOTATATE compared to 177Lu-PSMA radionuclide therapy. Radiat Environ Biophys. 2018;57(1):55\u201361.","journal-title":"Radiat Environ Biophys"},{"issue":"24","key":"408_CR23","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1056\/NEJMoa0810095","volume":"360","author":"M Bolla","year":"2009","unstructured":"Bolla M, de Reijke TM, Van Tienhoven G, Van den Bergh AC, Oddens J, Poortmans PM, Gez E, Kil P, Akdas A, Soete G, Kariakine O, van der Steen-Banasik EM, Musat E, Pi\u00e9rart M, Mauer ME, Collette L, EORTC Radiation Oncology Group and Genito-Urinary Tract Cancer Group. Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med. 2009;360(24):2516\u201327.","journal-title":"N Engl J Med"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-018-0408-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-018-0408-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-018-0408-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T19:08:30Z","timestamp":1562094510000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-018-0408-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1186\/s13550-018-0408-2","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"16 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from all included patients. The Medical Ethics Committee of the UMC Utrecht approved this prospective study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"56"}}